These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 16849519)

  • 1. Toll-like receptor 9 agonists promote cellular invasion by increasing matrix metalloproteinase activity.
    Merrell MA; Ilvesaro JM; Lehtonen N; Sorsa T; Gehrs B; Rosenthal E; Chen D; Shackley B; Harris KW; Selander KS
    Mol Cancer Res; 2006 Jul; 4(7):437-47. PubMed ID: 16849519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toll-like receptor 9 mediates CpG oligonucleotide-induced cellular invasion.
    Ilvesaro JM; Merrell MA; Li L; Wakchoure S; Graves D; Brooks S; Rahko E; Jukkola-Vuorinen A; Vuopala KS; Harris KW; Selander KS
    Mol Cancer Res; 2008 Oct; 6(10):1534-43. PubMed ID: 18922969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll like receptor-9 agonists stimulate prostate cancer invasion in vitro.
    Ilvesaro JM; Merrell MA; Swain TM; Davidson J; Zayzafoon M; Harris KW; Selander KS
    Prostate; 2007 May; 67(7):774-81. PubMed ID: 17373717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toll-like receptor 9 ligands enhance mesenchymal stem cell invasion and expression of matrix metalloprotease-13.
    Nurmenniemi S; Kuvaja P; Lehtonen S; Tiuraniemi S; Alahuhta I; Mattila RK; Risteli J; Salo T; Selander KS; Nyberg P; Lehenkari P
    Exp Cell Res; 2010 Oct; 316(16):2676-82. PubMed ID: 20553713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorothioate-modified TLR9 ligands protect cancer cells against TRAIL-induced apoptosis.
    Chiron D; Pellat-Deceunynck C; Maillasson M; Bataille R; Jego G
    J Immunol; 2009 Oct; 183(7):4371-7. PubMed ID: 19734228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia stimulates breast carcinoma cell invasion through MT1-MMP and MMP-2 activation.
    Muñoz-Nájar UM; Neurath KM; Vumbaca F; Claffey KP
    Oncogene; 2006 Apr; 25(16):2379-92. PubMed ID: 16369494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary breast myoepithelial cells exert an invasion-suppressor effect on breast cancer cells via paracrine down-regulation of MMP expression in fibroblasts and tumour cells.
    Jones JL; Shaw JA; Pringle JH; Walker RA
    J Pathol; 2003 Dec; 201(4):562-72. PubMed ID: 14648659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental therapy for colon cancer: anti-cancer effects of TLR9 agonism, combination with other therapeutic modalities, and dependence upon p53.
    Rayburn ER; Wang W; Zhang R; Wang H
    Int J Oncol; 2007 Jun; 30(6):1511-9. PubMed ID: 17487373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human lung cancer cells express functionally active Toll-like receptor 9.
    Droemann D; Albrecht D; Gerdes J; Ulmer AJ; Branscheid D; Vollmer E; Dalhoff K; Zabel P; Goldmann T
    Respir Res; 2005 Jan; 6(1):1. PubMed ID: 15631627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kalopanaxsaponin A inhibits PMA-induced invasion by reducing matrix metalloproteinase-9 via PI3K/Akt- and PKCdelta-mediated signaling in MCF-7 human breast cancer cells.
    Park SK; Hwang YS; Park KK; Park HJ; Seo JY; Chung WY
    Carcinogenesis; 2009 Jul; 30(7):1225-33. PubMed ID: 19420016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low TLR9 expression defines an aggressive subtype of triple-negative breast cancer.
    Tuomela J; Sandholm J; Karihtala P; Ilvesaro J; Vuopala KS; Kauppila JH; Kauppila S; Chen D; Pressey C; Härkönen P; Harris KW; Graves D; Auvinen PK; Soini Y; Jukkola-Vuorinen A; Selander KS
    Breast Cancer Res Treat; 2012 Sep; 135(2):481-93. PubMed ID: 22847512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-regulated p27Kip1 reduces matrix metalloproteinase-9 and inhibits invasion of human breast cancer cells.
    Mizuma M; Katayose Y; Yamamoto K; Shiraso S; Sasaki T; Yabuuchi S; Oda A; Masuda K; Rikiyama T; Onogawa T; Ohtsuka H; Motoi F; Egawa S; Unno M
    Anticancer Res; 2008; 28(5A):2669-77. PubMed ID: 19035293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrilysin over-expression in MCF-7 cells enhances cellular invasiveness and pro-gelatinase activation.
    Wang F; Reierstad S; Fishman DA
    Cancer Lett; 2006 May; 236(2):292-301. PubMed ID: 16019136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A molecular role for lysyl oxidase in breast cancer invasion.
    Kirschmann DA; Seftor EA; Fong SF; Nieva DR; Sullivan CM; Edwards EM; Sommer P; Csiszar K; Hendrix MJ
    Cancer Res; 2002 Aug; 62(15):4478-83. PubMed ID: 12154058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinases (MMPs) in breast cancer cell lines of different tumorigenicity.
    Bachmeier BE; Nerlich AG; Lichtinghagen R; Sommerhoff CP
    Anticancer Res; 2001; 21(6A):3821-8. PubMed ID: 11911253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short DNA sequences and bacterial DNA induce esophageal, gastric, and colorectal cancer cell invasion.
    Kauppila JH; Karttunen TJ; Saarnio J; Nyberg P; Salo T; Graves DE; Lehenkari PP; Selander KS
    APMIS; 2013 Jun; 121(6):511-22. PubMed ID: 23082743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proto-oncogene ACTR/AIB1 promotes cancer cell invasion by up-regulating specific matrix metalloproteinase expression.
    Li LB; Louie MC; Chen HW; Zou JX
    Cancer Lett; 2008 Mar; 261(1):64-73. PubMed ID: 18162290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrin fibronectin receptors in matrix metalloproteinase-1-dependent invasion by breast cancer and mammary epithelial cells.
    Jia Y; Zeng ZZ; Markwart SM; Rockwood KF; Ignatoski KM; Ethier SP; Livant DL
    Cancer Res; 2004 Dec; 64(23):8674-81. PubMed ID: 15574776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [6]-Gingerol inhibits metastasis of MDA-MB-231 human breast cancer cells.
    Lee HS; Seo EY; Kang NE; Kim WK
    J Nutr Biochem; 2008 May; 19(5):313-9. PubMed ID: 17683926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Additional MDA-MB-231 breast cancer cell matrix metalloproteinases promote invasiveness.
    Hegedüs L; Cho H; Xie X; Eliceiri GL
    J Cell Physiol; 2008 Aug; 216(2):480-5. PubMed ID: 18286480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.